These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19754750)

  • 1. Changing epidemiology of an emerging infection: zygomycosis.
    Meis JF; Chakrabarti A
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():10-4. PubMed ID: 19754750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Zygomycetes and zygomycosis in the new era of antifungal therapies].
    Torres-Narbona M; Guinea J; Muñoz P; Bouza E
    Rev Esp Quimioter; 2007 Dec; 20(4):375-86. PubMed ID: 18563211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of zygomycosis in transplant recipients.
    Cuenca-Estrella M; Bernal-Martinez L; Isla G; Gomez-Lopez A; Alcazar-Fuoli L; Buitrago MJ
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():37-40. PubMed ID: 19754755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging importance of infections due to zygomycetes in organ transplant recipients.
    Sun HY; Singh N
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S115-8. PubMed ID: 19013334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous zygomycosis.
    Skiada A; Petrikkos G
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():41-5. PubMed ID: 19754756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors.
    Ambrosioni J; Bouchuiguir-Wafa K; Garbino J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e100-3. PubMed ID: 20335060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zygomycosis--current epidemiological aspects.
    Glöckner A; Vehreschild JJ; Cornely OA
    Mycoses; 2007; 50 Suppl 1():50-5. PubMed ID: 17394610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation of zygomycosis.
    Mantadakis E; Samonis G
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():15-20. PubMed ID: 19754751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zygomycosis: the re-emerging fungal infection.
    Chayakulkeeree M; Ghannoum MA; Perfect JR
    Eur J Clin Microbiol Infect Dis; 2006 Apr; 25(4):215-29. PubMed ID: 16568297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
    Kontoyiannis DP; Lionakis MS; Lewis RE; Chamilos G; Healy M; Perego C; Safdar A; Kantarjian H; Champlin R; Walsh TJ; Raad II
    J Infect Dis; 2005 Apr; 191(8):1350-60. PubMed ID: 15776383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ecology of the Zygomycetes and its impact on environmental exposure.
    Richardson M
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():2-9. PubMed ID: 19754749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
    Roden MM; Zaoutis TE; Buchanan WL; Knudsen TA; Sarkisova TA; Schaufele RL; Sein M; Sein T; Chiou CC; Chu JH; Kontoyiannis DP; Walsh TJ
    Clin Infect Dis; 2005 Sep; 41(5):634-53. PubMed ID: 16080086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing epidemiology of invasive fungal infections: new threats.
    Maschmeyer G
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary zygomycosis.
    Pyrgos V; Shoham S; Walsh TJ
    Semin Respir Crit Care Med; 2008 Apr; 29(2):111-20. PubMed ID: 18365993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging fungal infections.
    Saliba F
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):419-21. PubMed ID: 22512751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing face of fungal infections in health care settings.
    Fridkin SK
    Clin Infect Dis; 2005 Nov; 41(10):1455-60. PubMed ID: 16231257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global epidemiology of cutaneous zygomycosis.
    Skiada A; Rigopoulos D; Larios G; Petrikkos G; Katsambas A
    Clin Dermatol; 2012; 30(6):628-32. PubMed ID: 23068150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management.
    Kontoyiannis DP; Lewis RE
    Infect Dis Clin North Am; 2006 Sep; 20(3):581-607, vi. PubMed ID: 16984870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
    Chamilos G; Lewis RE; Kontoyiannis DP
    Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
    J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.